PMID- 36185700 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20221004 IS - 2296-861X (Print) IS - 2296-861X (Electronic) IS - 2296-861X (Linking) VI - 9 DP - 2022 TI - Purification, structural characterization and immunological activity of Sibiraea laexigata (L.) Maxim polysaccharide. PG - 1013020 LID - 10.3389/fnut.2022.1013020 [doi] LID - 1013020 AB - Sibiraea laexigata (L.) Maxim (SLM) has been used as an herbal tea for treating stomach discomfort and indigestion for a long time in china. Polysaccharides have been identified as one of the major bioactive compounds in the SLM. In the present paper, ultrasonic-assisted enzymatic extraction (UAEE) method was employed in polysaccharides extraction derived from SLM using polyethylene glycol (PEG) as extraction solvent, two SLM polysaccharides (SLMPs) fractions (SLMPs-1-1 and SLMPs-2-1) were purified by DEAE Cellulose-52 and Sephadex G-100 chromatography in sequence. Then, the preliminarily structure of the two factions were characterized by chemical composition analysis, molecular weight measurement, UVS, HPLC-PMP, FT-IR, nuclear magnetic resonance (NMR) spectra analysis and SEM. The results showed that SLMPs-1-1 and SLMPs-2-1 with different molecular weights of 1.03 and 1.02 kDa, mainly composed of glucose (46.76 and 46.79%), respectively. The results of structural characterization from FT-IR, (1)H NMR, and SEM revealed that SLMPs-1-1 and SLMPs-2-1 contained the typical pyranoid polysaccharide with alpha-glycosidic bond and beta-glycosidic bond. Furthermore, it was found that SLMPs-1-1 could increase the levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin-2 (IL-2), and alleviated the immune organs tissue damage of cyclophosphamide (Cy)-treated mice. RT-qPCR and Western-Blot analysis showed that SLMPs-1-1 could significantly up-regulated the levels of NF-kappaB, TLR4, which revealed that SLMPs-1-1 could participate in immunosuppressive protection of Cy-treated mice. These findings suggested that the potential of SLMPs-1-1 as an alternative immunostimulator could be used in food and pharmaceutical industries. CI - Copyright (c) 2022 Yang, Liu, Yang, Ma, Guo, Chen and Gao. FAU - Yang, Xuhua AU - Yang X AD - China-Malaysia National Joint Laboratory, College of Life Sciences and Engineering, Northwest Minzu University, Lanzhou, China. FAU - Liu, Honghai AU - Liu H AD - Technology Research and Development Center, Gansu Tobacco Industry Co., Ltd., Lanzhou, China. FAU - Yang, Jutian AU - Yang J AD - China-Malaysia National Joint Laboratory, College of Life Sciences and Engineering, Northwest Minzu University, Lanzhou, China. AD - Taizishan Ecosystem Observatory of Carbon Neutralization, Northwest Minzu University, Lanzhou, China. FAU - Ma, Zhongren AU - Ma Z AD - China-Malaysia National Joint Laboratory, College of Life Sciences and Engineering, Northwest Minzu University, Lanzhou, China. FAU - Guo, Penghui AU - Guo P AD - China-Malaysia National Joint Laboratory, College of Life Sciences and Engineering, Northwest Minzu University, Lanzhou, China. AD - Taizishan Ecosystem Observatory of Carbon Neutralization, Northwest Minzu University, Lanzhou, China. FAU - Chen, Hong AU - Chen H AD - China-Malaysia National Joint Laboratory, College of Life Sciences and Engineering, Northwest Minzu University, Lanzhou, China. FAU - Gao, Dandan AU - Gao D AD - China-Malaysia National Joint Laboratory, College of Life Sciences and Engineering, Northwest Minzu University, Lanzhou, China. AD - Taizishan Ecosystem Observatory of Carbon Neutralization, Northwest Minzu University, Lanzhou, China. LA - eng PT - Journal Article DEP - 20220915 PL - Switzerland TA - Front Nutr JT - Frontiers in nutrition JID - 101642264 PMC - PMC9521201 OTO - NOTNLM OT - Sibiraea laexigata (L.) Maxim OT - immunological activity OT - polysaccharides OT - purification OT - structural characterization COIS- Author HL was employed by the Gansu Tobacco Industry Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/10/04 06:00 MHDA- 2022/10/04 06:01 PMCR- 2022/01/01 CRDT- 2022/10/03 04:23 PHST- 2022/08/06 00:00 [received] PHST- 2022/08/29 00:00 [accepted] PHST- 2022/10/03 04:23 [entrez] PHST- 2022/10/04 06:00 [pubmed] PHST- 2022/10/04 06:01 [medline] PHST- 2022/01/01 00:00 [pmc-release] AID - 10.3389/fnut.2022.1013020 [doi] PST - epublish SO - Front Nutr. 2022 Sep 15;9:1013020. doi: 10.3389/fnut.2022.1013020. eCollection 2022.